CD274 and melanoma: Interestingly, high FDX1 expression in melanoma is linked to improved response to anti-PD-L1 immunotherapy (Lu et al., 2023), but FDX1 knockdown inhibits the in vitro proliferation of melanoma cells (Liu et al., 2022).